Skip to main content

Ardelyx, Inc.

ARDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001437402

In the last 90 days, Ardelyx, Inc. insiders filed 0 open-market purchases and 9 sales; 250 institutions reported holding it in 13F filings for Q2 2026, worth $906.4M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Ardelyx, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
9 filings
8 insiders, $697.1K in total
Insiders trading
8
Net value
−$697.1K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Ardelyx, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Ardelyx, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Hohenleitner SusanChief Financial Officer227,520Aug 25, 20264
Reilly Joseph JamesSee Remarks145,854Aug 25, 20265
Bishop John ESee Remarks317,095Aug 25, 20264
Brady James ParkerChief Human Resources Officer245,930Aug 25, 20264
Foster Eric DuaneChief Commercial Officer409,410Aug 25, 20265
Kelliher MikeChief Business Officer349,660Aug 25, 20265
Williams Laura AChief Patient Officer367,456Aug 25, 20267
Raab MichaelPresident & CEO1,619,792Aug 25, 202611
Mott David MDirector3,349,655Jun 18, 20262
Bertrand William C JRDirector329,507Jun 18, 20261
Rodgers Richard JDirector439,998Jun 18, 20261
Bazemore Robert BDirector68,006Jun 18, 20261
Parsey MerdadDirector83,746Jun 18, 20261
Cadoret-Manier OnaizaDirector178,156Jun 18, 20261
Bhanji MunaDirector163,808Jun 18, 20261
Grammer Elizabeth ASee Remarks299,895Nov 25, 20251
Renz Justin AChief Financial Officer409,052Aug 25, 20250
Rosenbaum David P.Chief Development Officer151,373IndirectNov 22, 20240
Blanks RobertSee Remarks314,421Nov 22, 20240
Felsch Robert OraSee Remarks91,560Aug 22, 20240
Rodriguez SusanChief Commercial Officer449,092May 23, 20240
Lundberg Jan MDirector146,794Jun 16, 20230
Block Geoffrey A.Director–Jun 16, 20230
Sandell Scott D10% Owner2,258,850IndirectDec 27, 20210
Baskett Forest10% Owner2,258,850IndirectDec 27, 20210
Jacobs Jeffrey WChief Scientific Officer119,483Nov 24, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 22, 2025 (view filing)May 202 daysRaab MichaelPresident & CEOSSale−46.8K$4.08−$191.0K−2.9%1.55M after
May 22, 2025 (view filing)May 202 daysKelliher MikeSee RemarksSSale−14.5K$4.08−$59.2K−4.9%282.2K after
May 22, 2025 (view filing)May 202 daysGrammer Elizabeth ASee RemarksSSale−5.99K$4.08−$24.4K−1.9%311.7K after
May 22, 2025 (view filing)May 202 daysFoster Eric DuaneChief Commercial OfficerSSale−2.51K$4.08−$10.2K−0.8%316.8K after
May 19, 2025 (view filing)May 154 daysMott David MDirectorPPurchase+100.0K$3.29+$329.0K+4.2%2.50M after
May 5, 2025 (view filing)May 23 daysMott David MDirectorPPurchase+381.4K$4.22+$1.61M+18.9%2.40M after
May 5, 2025 (view filing)May 23 daysRaab MichaelPresident & CEOSSale−41.7K$4.25−$177.1K−2.5%1.59M after10b5-1
Apr 8, 2025 (view filing)Apr 44 daysRaab MichaelPresident & CEOSSale−41.7K$4.59−$191.2K−2.5%1.62M after10b5-1
Mar 7, 2025 (view filing)Mar 7Same dayRaab MichaelPresident & CEOSSale−41.7K$5.36−$223.3K−2.5%1.64M after10b5-1
Feb 26, 2025 (view filing)Feb 242 daysMott David MDirectorPPurchase+77.7K$5.00+$388.6K+4.0%2.02M after
Feb 21, 2025 (view filing)Feb 201 dayWilliams Laura AChief Medical OfficerSSale−4.94K$5.62−$27.8K−1.6%303.8K after
Feb 21, 2025 (view filing)Feb 201 dayRenz Justin AChief Financial OfficerSSale−5.17K$5.62−$29.1K−1.8%286.0K after
Feb 21, 2025 (view filing)Feb 201 dayRaab MichaelPresident & CEOSSale−23.0K$5.62−$129.1K−2.1%1.09M after
Feb 21, 2025 (view filing)Feb 201 dayGrammer Elizabeth ASee RemarksSSale−4.29K$5.62−$24.1K−2.3%181.0K after
Jan 31, 2025 (view filing)Jan 31Same dayRaab MichaelPresident & CEOSSale−41.7K$5.36−$223.3K−3.6%1.11M after10b5-1
Jan 22, 2025 (view filing)Jan 211 dayMott David MDirectorPPurchase+199.0K$4.99+$993.0K+11.4%1.94M after
Jan 10, 2025 (view filing)Jan 73 daysRaab MichaelPresident & CEOSSale−41.7K$5.31−$221.2K−3.6%1.13M after10b5-1
Dec 23, 2024 (view filing)Dec 194 daysMott David MDirectorPPurchase+213.3K$4.67+$996.1K+15.0%1.64M after
Dec 12, 2024 (view filing)Dec 102 daysRaab MichaelPresident & CEOSSale−25.0K$5.26−$131.5K−2.1%1.15M after10b5-1
Nov 27, 2024 (view filing)Nov 252 daysRaab MichaelPresident & CEOSSale−25.0K$5.38−$134.5K−2.1%1.15M after10b5-1
Nov 22, 2024 (view filing)Nov 202 daysWilliams Laura AChief Medical OfficerSSale−7.37K$4.79−$35.3K−2.3%308.7K after
Nov 22, 2024 (view filing)Nov 202 daysRosenbaum David P.Chief Development OfficerSSale−4.94K$4.79−$23.7K−1.6%297.0K after
Nov 22, 2024 (view filing)Nov 202 daysRosenbaum David P.Chief Development OfficerSSale−2.24K$4.79−$10.7K−1.5%151.4K after
Nov 22, 2024 (view filing)Nov 202 daysRenz Justin AChief Financial OfficerSSale−5.26K$4.79−$25.2K−1.8%291.1K after
Nov 22, 2024 (view filing)Nov 202 daysRaab MichaelPresident & CEOSSale−32.0K$4.79−$153.2K−2.6%1.18M after
Nov 22, 2024 (view filing)Nov 202 daysGrammer Elizabeth ASee RemarksSSale−7.05K$4.79−$33.8K−3.7%185.3K after
Nov 22, 2024 (view filing)Nov 202 daysBlanks RobertSee RemarksSSale−4.94K$4.79−$23.7K−1.5%314.4K after
Nov 14, 2024 (view filing)Nov 131 dayMott David MDirectorPPurchase+215.9K$4.62+$997.3K+17.8%1.43M after
Nov 12, 2024 (view filing)Nov 111 dayRaab MichaelPresident & CEOSSale−2.74K$4.90−$13.4K−0.2%1.21M after10b5-1
Nov 8, 2024 (view filing)Nov 62 daysRosenbaum David P.Chief Development OfficerSSale−27.2K$6.10−$165.7K−15.0%153.6K after
Nov 6, 2024 (view filing)Nov 42 daysRosenbaum David P.Chief Development OfficerSSale−27.2K$5.95−$161.7K−15.0%153.6K after
Oct 31, 2024 (view filing)Oct 283 daysLateRaab MichaelPresident & CEOSSale−25.0K$5.91−$147.8K−2.0%1.21M after10b5-1
Oct 15, 2024 (view filing)Oct 114 daysRaab MichaelPresident & CEOSSale−7.50K$6.01−$45.1K−0.6%1.21M after10b5-1
Oct 1, 2024 (view filing)Sep 274 daysRosenbaum David P.Chief Development OfficerSSale−49.6K$6.92−$343.0K−14.1%301.9K after10b5-1
Sep 27, 2024 (view filing)Sep 261 dayRaab MichaelPresident & CEOSSale−3.00K$6.07−$18.2K−0.2%1.22M after10b5-1
Sep 16, 2024 (view filing)Sep 133 daysRosenbaum David P.Chief Development OfficerSSale−5.31K$6.26−$33.3K−3.3%153.6K after
Sep 13, 2024 (view filing)Sep 112 daysRaab MichaelPresident & CEOSSale−35.0K$5.61−$196.3K−2.8%1.22M after
Aug 28, 2024 (view filing)Aug 271 dayRaab MichaelPresident & CEOSSale−7.50K$6.22−$46.6K−0.6%1.22M after10b5-1
Aug 22, 2024 (view filing)Aug 202 daysWilliams Laura AChief Medical OfficerSSale−7.41K$5.86−$43.4K−2.3%314.7K after
Aug 22, 2024 (view filing)Aug 202 daysRosenbaum David P.Chief Development OfficerSSale−4.97K$5.86−$29.1K−1.4%351.5K after
Aug 22, 2024 (view filing)Aug 202 daysRosenbaum David P.Chief Development OfficerSSale−2.25K$5.86−$13.2K−1.4%156.3K after
Aug 22, 2024 (view filing)Aug 202 daysRenz Justin AChief Financial OfficerSSale−5.29K$5.86−$31.0K−1.8%295.3K after
Aug 22, 2024 (view filing)Aug 202 daysRaab MichaelPresident & CEOSSale−32.2K$5.86−$188.8K−2.6%1.23M after
Aug 22, 2024 (view filing)Aug 202 daysGrammer Elizabeth ASee RemarksSSale−7.09K$5.86−$41.5K−3.6%192.4K after
Aug 22, 2024 (view filing)Aug 202 daysFelsch Robert OraSee RemarksSSale−3.57K$5.86−$20.9K−3.7%91.6K after
Aug 22, 2024 (view filing)Aug 202 daysBlanks RobertSee RemarksSSale−4.97K$5.86−$29.1K−1.5%319.4K after
Aug 20, 2024 (view filing)Aug 164 daysRosenbaum David P.Chief Development OfficerSSale−20.0K$5.94−$118.8K−5.3%356.5K after10b5-1
Aug 20, 2024 (view filing)Aug 20Same dayRosenbaum David P.Chief Development OfficerSSale−20.5K$6.00−$123.0K−11.5%158.5K after10b5-1
Aug 14, 2024 (view filing)Aug 122 daysRaab MichaelPresident & CEOSSale−1.23K$5.71−$7.02K−0.1%1.26M after10b5-1
Jul 31, 2024 (view filing)Jul 292 daysRaab MichaelPresident & CEOSSale−30.0K$5.64−$169.2K−2.3%1.26M after10b5-1